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a progressive increase throughout the experiment. ApoptosisMechanism of chronic obstructive uropathy: Increased expres-
was minimal at all experimental time points for control andsion of apoptosis-promoting molecules.
contralateral kidneys. Compared with control and contralateralBackground. We have demonstrated that renal tubular and
kidneys, the ligated kidneys displayed a dynamic expressioninterstitial cells undergo pronounced apoptosis during the
of mRNAs for many apoptosis-related molecules, which in-course of chronic obstructive uropathy (COU). Apoptosis is a
complex cellular process consisting of multiple steps, each of cluded an up to threefold increase for Fas, Fas ligand, TNF-R1,
which is mediated by families of related molecules. These fami- TRAIL, TRADD, RIP, and caspase-8, and an up to twofold
lies may include receptor/ligand molecules such as Fas, Fas li- increase for FADD and FAP, but there was little change for
gand, tumor necrosis factor receptor-1 (TNFR-1), and TNF- FAF. These mRNAs increased between days 4 and 15, decreased
related apoptosis inducing ligand (TRAIL); signal transduction until day 30, but then increased again until day 45. The rise
adapter molecules such as Fas-associated death domain (FADD), and fall of mRNAs between days 4 and 30 paralleled a similar
TNFR-1 associated death domain (TRADD), receptor-inter- fluctuation in tubular cell apoptosis in that period. The subse-
acting protein (RIP), Fas-associated factor (FAF), and Fas- quent increase of mRNAs was correlated with a continuous
associated phosphatase (FAP); or effector molecules such as rise of interstitial cell apoptosis. We demonstrated a positive
caspases. However, the mechanism of tubular cell apoptosis, immunostaining for Fas and Fas ligand in the tubular cells at
as well as the pathogenetic relevance of these apoptosis-related early time points as well as in interstitial inflammatory cells at
molecules in COU, remains poorly understood. later time points. Although increased expression of TRAIL,
Methods. Kidneys were harvested from sham-operated con- TRADD, RIP, and caspase-8 was noted in tubular cells, there
trol mice and mice with COU created by left ureter ligation was no staining for these molecules in interstitial cells.
sacrificed in groups of three at days 4, 15, 30, and 45. To detect Conclusion. The current study documents a dynamic expres-
apoptotic tubular and interstitial cells, in situ end labeling of sion of several molecules that are known to mediate the most
fragmented DNA was performed. To detect the expression of crucial steps of apoptosis. It implicates these molecules in
apoptosis-related molecules, ribonuclease protection assay was COU-associated renal cell apoptosis and in the pathogenesis
used with specific antisense RNA probes for Fas, Fas ligand, of this condition. It also lays the foundation for interventional
TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and cas- studies, including genetic engineering, to evaluate the molecu-
pase-8. Immunostaining for Fas, Fas ligand, TRAIL, TRADD, lar control of apoptosis associated with COU.
RIP, and caspase-8 was also performed. To assess the role of
these molecules in COU-associated renal cell apoptosis, the
frequencies of apoptotic tubular and interstitial cells were sepa-
rately quantitated for each experimental time point, and their Obstruction of urine outflow results in a constellation
patterns of variation were correlated with those of apoptosis- of renal parenchymal changes collectively called chronic
related molecules. obstructive uropathy (COU). These changes include tu-Results. The obstructed kidneys displayed increased apopto-
bular atrophy, interstitial fibrosis, and interstitial inflam-sis of both tubular and interstitial cells. Tubular cell apoptosis
mation, all of which are associated with progressive renalappeared at day 4 after ureter ligation, peaked (fivefold of
control) at day 15, and decreased gradually until the end of tissue loss [1–4]. We have previously demonstrated in a
the experiment. In contrast, interstitial cell apoptosis sustained rat model of COU created by unilateral ureteral ligation
that a significant number of tubular cells undergo apo-
ptosis. This process may be pathogenetically importantKey words: tubular cell apoptosis, interstitial cell apoptosis, ribo-
nuclease protection assay, obstructive uropathy, cell death. since it could be a major factor responsible for the pro-
gressive renal tissue loss seen in kidneys with COU. In
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Apoptosis is a genetically determined process of cell METHODS
death involving multiple distinct steps, each of which Experimental design
is under strict control by timely expressed molecules Under inhalation anesthesia with methoxyflurane,
belonging to one of three distinct families, that is, recep- C57B16 male mice (Harlan Animal Farm, Houston, TX,
tor/ligand, adapter, and effector families [6–11]. Al- USA) weighing 25 to 35 g were subjected to complete
though the mechanism and the essential components of ligation of the left ureter at the ureteropelvic junction
apoptosis remain to be elucidated, it is generally ac- using double silk suture. Animals were subsequently
cepted that apoptosis is initiated by a direct physical placed on a regular diet and allowed free access to tap
interaction between a variety of death signals in the water and were then sacrificed at days 4, 15, 30, and 45.
extracellular environment and their death receptors, in- These time points were chosen since, in a pilot study,
they were shown to span the entire quantitative spectrumcluding Fas, tumor necrosis factor receptor-1 (TNFR-1),
of tubular and interstitial cell apoptosis. Three to sixand TNF-related apoptosis inducing ligand (TRAIL) re-
mice were used for each time point. For control, a groupceptor, which are strategically situated on the cell mem-
of six mice was sham-operated and sacrificed at day 0.brane. Apoptosis is initiated when these receptors are
engaged by their ligands, that is, Fas ligand, TNF, and
Tissue preparation
TRAIL, respectively, which are either free in the circula-
Control, ligated, and contralateral kidneys were har-tion or bound to the membrane of cytotoxic effector
vested. Portions of the obtained kidney tissue were fixedcells [6, 9, 11–20]. The death receptor/ligand complexes,
in 10% buffered formalin for routine histology and inin turn, bind to specialized domains of several intracellu-
situ end labeling of fragmented DNA. Other portionslar molecules collectively called adapter molecules, which
were frozen in embedding media (OCT compound;
include TNFR-1 associated death domain (TRADD),
Sakura Finetek, Torrance, CA, USA) for frozen sec-
receptor-interacting protein (RIP), Fas-associated death tion immunohistochemistry. Both frozen and paraffin-
domain (FADD), Fas-associated factor (FAF), and Fas- embedded kidney tissues were cut into 4 mm sections
associated phosphatase (FAP) [9, 21–29]. The activated for subsequent staining. The remaining kidney tissues
adapter molecules, then, trigger a cascade of intracellular from animals of the same experimental duration were
signal transduction, resulting in an orderly activation pooled together and snap frozen in liquid nitrogen at
of a family of cytosolic or nuclear proteolytic enzymes 2708C for subsequent RNA extraction.
collectively called caspases. Caspases [8, 10, 30] serve as
Detection of tubular cell apoptosis by in situ endthe final effector molecules of the death pathway and
labeling of fragmented DNAsare responsible for most of the structural changes that are
observed in apoptotic cells regardless of origin. Among One of the most sensitive and specific markers for apo-
ptosis is fragmentation of nuclear DNA. For the detectionmembers of this family, caspase-8 is probably the most
of tubular cell apoptosis, in situ end labeling of fragmentedcritical molecule since it represents the last element in
DNA was performed as previously detailed [5].the chain event connecting death signals to other cas-
pases [8, 10, 30, 31]. Among these molecules, FAP is the
Ribonuclease protection assayonly one that inhibits apoptosis, whereas the remainders
The ribonuclease (RNase) protection assay (RPA) wasare apoptosis promoters.
used to detect and quantitate the expression of mRNAsAlthough apoptosis of tubular or interstitial cells rep-
of apoptosis-related molecules in kidney tissue [32, 33].resents a pathogenetically fundamental change in COU,
A cocktail of probes is used to detect simultaneouslyhow it happens has not been elucidated. To lay the foun-
the mRNAs of several preselected functionally relateddation for investigation in this direction, we have at-
molecules. The assay was performed as follows. For eachtempted to catalog and quantitate the renal expression
time point, kidney tissue from three to six animals was
of mRNAs of the apoptosis-related molecules mentioned pooled together, and total cellular RNA was isolated
previously in this article in a model of COU created by from control, ligated, and contralateral kidney using the
unilateral ureter ligation in mice. Against the background RNAzol-B method, according to the manufacturer’s in-
of an ever-increasing number of apoptosis-related mole- structions (Tel-Test, Friendswood, TX, USA). Subse-
cules that may or may not be pertinent to apoptosis of quently, RNase protection assay was performed using
a specific cell population in a single organ, this approach RiboQuant RNase protection assay kit (Pharmingen, San
should not only offer an insight into what molecules are Diego, CA, USA). This kit contained cDNA templates for
relevant to apoptosis in kidneys with COU, but also pro- Fas, Fas ligand, TNFR-1, TRAIL, TRADD, RIP, FADD,
vide some guidelines for subsequent focus on the mole- FAF, FAP, and caspase-8. The kit also contained cDNA
templates for ribosomal protein L32 and glyceraldehydecules that are up-regulated in a faithful fashion in COU.
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3-phosphate dehydrogenase (GAPDH) as internal con- apoptotic cells against the total number of tubular cells in
the same fields. Quantitation of interstitial cell apoptosistrols. Labeled antisense RNA probes were synthesized
from these cDNA templates using [a-32P] UTP in an in was also performed in the same manner. It should be
noted that although both interstitial fibroblasts and inter-vitro transcription reaction performed according to the
manufacturer’s instruction and hybridized with 10 mg stitial inflammatory cells underwent apoptosis, it is not
possible to differentiate precisely these two types of cellsof total RNA extracted from the control, ligated, and
contralateral kidneys for 16 hours at 568C. The hybrid- when they become apoptotic. Separate quantitation for
them, therefore, was not carried out. Immunostainingized products were treated with a digestion mixture in-
cluding RNase and proteinase. During this procedure, for the previously mentioned antibodies was evaluated
on a 0 to 41 scale (0 5 no staining, 11 5 less than 10%the unhybridized RNAs and the free RNA probes were
digested, but the hybridized RNAs were protected from of cells stained, 21 5 10 to 30%, 31 5 30 to 70%, and
41 5 70 to 100%). For this purpose, 5 to 10 randomdigestion (RNase protection assay). The hybridized RNAs
were heat denatured and electrophoresed on polyacryl- fields were evaluated under 320 magnification.
amide gel for two hours at 50 W at 45 to 508C. The gel
was then dried and exposed to x-ray film at 2708C. The
RESULTS
resultant bands were scanned and quantitated using Pho-
Pathologic findingstoShop and UTHSCSA software. Band intensity was
normalized to that of GAPDH in the same reaction. The The ligated kidneys uniformly developed COU char-
acterized by progressive tubulointerstitial changes, whereasassay was performed three times on the pooled RNA.
To confirm the original observations, RPA was also re- the glomeruli and blood vessels remained normal through-
out the experimental period. The tubular changes in-peated on pooled renal tissues from new groups of mice
subjected to unilateral ureteral ligation, following the cluded atrophy, dilation, and simplification of the tubular
epithelium, and tubular cell apoptosis; the interstitialsame protocols for those included in the original study.
The data were expressed as means 6 SD of the results changes included fibrosis, inflammatory cell infiltration,
increased number of fibroblasts, and apoptosis of inter-obtained from the original and the repeated studies.
stitial cells. No significant changes were noted in the
Immunohistochemical staining control and contralateral kidneys (Fig. 1).
Immunostaining was performed to assess the cellu-
Apoptosislar sources of the up-regulated apoptosis-related mole-
cules. Immunostaining for Fas and Fas ligand was done Although rare apoptotic tubular or interstitial cells
were noted in routine tissue preparation, accurate identi-with affinity-purified and immunohistochemically suit-
able rabbit polyclonal antibodies, which were success- fication and quantitation of apoptotic cells were greatly
facilitated by in situ end labeling for fragmented DNAfully developed in our laboratories. These antibodies
have been shown to be monospecific by Western blotting (Fig. 2A, B). Tubular cell apoptosis was first noted at
day 4 after ureteral ligation, increased and peaked (five-[34]. Recently, monospecific rabbit polyclonal antibodies
for TRAIL, TRADD, RIP, and caspase-8 p20 have also fold of control) at day 15, subsequently decreased rapidly
until day 30, and then decreased gradually until the endbecome available (Santa Cruz, Santa Cruz, CA, USA).
They were used for immunostaining in this study. Forma- of the experiment (Fig. 3A). Apoptotic interstitial cells
were less numerous than apoptotic tubular cells in thelin-fixed, paraffin-embedded tissue sections were used
for antibodies against Fas (1:200 dilution) and Fas ligand initial phase of the study, but gradually increased through-
out the entire experimental period (Fig. 3B). Although(1:100 dilution). Frozen tissue sections were used for
antibodies against TRAIL, TRADD, RIP, and caspase-8 it was not possible to differentiate the types of interstitial
cells that underwent apoptosis, inflammatory cells werep20 (1:50 dilution for each antibody). The antibody
against caspase 8 p20 recognizes both the proenzyme and probably the more frequent cell types, especially toward
the end of the experiment. Apoptotic cells were rarelyits p20 activation fragment. A standard avidin-biotin-
peroxidase technique was performed for control, contra- seen in the glomeruli and were virtually not present in
control or contralateral kidneys throughout the experi-lateral, and ligated kidney tissue sections. Positive and
negative controls were also included. ment.
RNase protection assay forQuantitative studies
apoptosis-related moleculesTubular cells undergoing apoptosis were quantitated
by counting, under a 340 eyepiece of a Nikon micro- The results of the original and the repeated studies
were similar. The mRNAs of several apoptosis-relatedscope, all apoptotic tubular cells within 5 to 10 random
fields in either cortex or medulla. The frequency of apo- molecules were identified at a low level in control kid-
neys. The contralateral kidneys displayed the same pat-ptotic tubular cells was expressed as the percentage of
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Fig. 1. Light microscopy. (A) A ligated kidney at day 15 shows tubular
atrophy, interstitial fibrosis, interstitial inflammation, and interstitial
fibroblast proliferation. (B) The corresponding contralateral kidney
does not show any significant changes and is similar to the control
kidney (hematoxylin and eosin, 31200).
terns of mRNA expression as those of controls, except
for mild but sustained increase of mRNA for RIP. In
contrast, the ligated kidneys displayed a dynamic expres-
sion of mRNAs for almost all tested apoptosis-related
molecules (Fig. 4).
Receptor/ligand family. The tested molecules that be-
long to the receptor/ligand family, that is, Fas, Fas ligand,
TNFR-1, and TRAIL, displayed a marked mRNA in-
crease. The increase for Fas and Fas ligand was more
than twofold between days 4 to 15 and was fourfold at
day 45. The increase for TNFR-1 was more than twofold
between days 4 to 45. TRAIL increased gradually to
twofold at day 4 and to more than threefold between
days 15 to 45.
Adapter molecule family. The tested molecules that
belong to the adapter molecule family (TRADD, RIP,
FADD, FAF, and FAP) showed variable increase of Fig. 2. Renal cell apoptosis. (A) A ligated kidney at day 15 displays
mRNA expression through the experiments. The mRNA pronounced tubular cell apoptosis as detected by a positive in situ end
labeling for fragmented DNA. (B) Apoptotic interstitial cells are notedfor TRADD was increased about fourfold between days
in a ligated kidney at day 30. (C ) Only a rare apoptotic cell is noted
4 to 15, decreased about twofold between days 15 to 30, in the corresponding contralateral kidney, a pattern also observed in
control kidney.and increased again until day 45. RIP displayed a gradual
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Fig. 3. The frequency of apoptotic cells. (A) The frequency of tubular cell apoptosis in ligated kidneys peaks at day 15 and decreases gradually
to the level of contralateral kidneys. (B) Apoptotic interstitial cells are gradually increased throughout the experimental duration. Symbols are:
(d) contralateral mean; (j) ligated mean.
increase of mRNA expression throughout the experi- munolocalized in tubular cells, especially the atrophic
ment that reached threefold at day 45. FADD and FAF ones, in ligated kidneys (Fig. 5). The expression in-
displayed a similar pattern characterized by a slight in- creased with the duration of urinary obstruction (11 at
crease reaching less than twofold at day 45. FAP, the day 4, 2 to 31 in cortex and medulla between days 15
only apoptosis inhibitor in this study, was slightly up- to 30, and 31 at day 45). Interstitial cells were also
regulated between days 4 to 30 but sustained a twofold stained for Fas and Fas ligand with increasing frequency
increase between days 30 to 45. toward the end of the study (Fig. 5). It is not possible
Effector family. The mRNA for caspase-8, which be- to determine with certainty whether the stained cells are
longs to the effector family, displayed a gradual increase inflammatory cells or interstitial fibroblasts or both.
throughout the experiment, reaching twofold between TRAIL, TRADD, RIP, and caspase-8 p20 showed a
days 4 to 30 and then threefold at day 45. similar staining pattern. There was no or weak and focal
staining for these molecules in proximal tubules of con-
Correlation of the mRNA expression and apoptosis of trol or contralateral kidneys. In the ligated kidneys, there
tubular and interstitial cells was progressive and unequivocal staining of each of these
molecules in the cytoplasm of damaged tubular cells,The patterns of mRNA expression of apoptosis-pro-
even in the ones without features of apoptosis; the stain-moting molecules in obstructed kidneys in the early
ing was most pronounced between days 4 and 15, becamephase paralleled those of tubular cell apoptosis. The
less strong subsequently, but persisted toward the endincreased expression between days 4 to 15 followed by
of the experiment (Fig. 5). There was no staining of thea decreased expression between days 15 to 30 correlated
interstitial cells at any time point. None of the testedwith a similar rise and fall of tubular cell apoptosis. This
molecules were found in glomeruli or blood vessels ofobservation suggested that tubular cell apoptosis was
any kidney.mediated by these molecules. However, a continuous
rise was noted for most apoptosis-promoting molecules
beyond day 30, during which time tubular cell apoptosis
DISCUSSIONsubsided. This was probably attributed to a continuous
Kidneys with COU in both humans and experimentalincrease of interstitial cells at these time points. The
animals develop progressive tubulointerstitial damage,pattern of expression of FAP, the only anti-apoptotic
whereas the glomeruli and vessels are well preservedmolecule in this study (a slight increase between days 4
even in the late phase of the disease [2, 3, 5, 35]. Althoughto 30 followed by a more pronounced increase reaching
several tubular changes such as dilation, atrophy, or im-twofold at day 45) paralleled a decrease of tubular cell
mature phenotype have been well recognized, tubularapoptosis between days 15 to 45.
cell apoptosis has recently emerged as a crucial lesion
Immunohistochemistry for in COU [1, 3, 5, 36]. It has been suggested that tubular
apoptosis-promoting molecules cell apoptosis is not only pathogenetically related to
other tubular changes in COU, but may also be responsi-Fas or Fas ligand was not identified in control or con-
tralateral kidneys. In contrast, these molecules were im- ble for the profound renal tissue loss characteristic of
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this condition. Interstitial damage, including fibrosis, in-
flammatory cell infiltrate, and vascular remodeling, is
also seen in COU, the severity of which was recently
shown to correlate positively with the extent of intersti-
tial cell apoptosis [5]. These observations strongly imply
a disturbance of tubular and interstitial cell cycles, in-
cluding an increased apoptosis of these cells, in the
pathogenesis of COU.
How the general mechanism of apoptosis, gleaned
mostly from in vitro studies, is relevant to that of renal
cell apoptosis in COU has not been evaluated. A large
number of environmental factors known to cause apo-
ptosis, such as hypoxia, ischemia, cytokines, growth fac-
tors, angiotensin II, and reactive oxygen species [3], are
all activated during the course of COU, but it remains
unclear whether they are, indeed, the initiators of apo-
ptosis in this condition [37–39]. Another fundamental
question is which ones, among the large number of
known apoptosis-related molecules, are functional in
COU. This question, indeed, is relevant since it has been
amply demonstrated that apoptosis can proceed through
different distinct pathways, each of which may be tissue
or cell specific and may be mediated by different sets of
molecules [6–10, 17–31].
In an attempt to answer some of these questions, we
have successfully created COU by unilateral ligation of
mice’s ureters and established characteristic patterns of Fig. 4. Ribonuclease protection assay. (A) The ribonuclease protection
assay blot demonstrates a low level of apoptosis-related molecules inrenal tubular and interstitial cell apoptosis as a function
control (lane 1) and contralateral (R; lane 2) kidneys at day 15. Inof experimental duration. These patterns were subse- contrast, the ligated (L) kidneys at various experimental duration (lanes
quently correlated with the quantity of the mRNAs of 3, 4, 5, and 6) show a marked increase of mRNA expression for Fas,
Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8. FADD,several apoptosis-related molecules, which were shown
FAF, and FAP were slightly increased. (B ) The patterns of expressionby the ribonuclease protection assay to be up-regulated of individual apoptosis-related molecules. The individually illustrated
in kidneys with COU. Ribonuclease protection assay, blots are taken from the composite blot shown in A. The data represent
means 6 SD of the results obtained from the original and the repeatedwhich represents a recent modification of the traditional
studies.Northern hybridization, is an ideal method for simultane-
ous evaluation of mRNAs of several target molecules
[32, 33]. This approach is made possible by a technique
that allows for the synthesis of several antisense RNA cell apoptosis between days 4 and 30 parallel the pattern
of mRNA expression for all tested apoptosis-relatedprobes of related molecules by in vitro transcription and
the simultaneous use of these probes in the hybridization. molecules, including Fas, Fas ligand, tumor necrosis fac-
tor receptor type 1 (TNFR-1), TRAIL (receptor/ligandIt is more sensitive and reliable than Northern hybridiza-
tion and more quantitative than reverse transcriptase- family); FADD, TRADD, RIP, FAF, FAP (adapter fam-
ily); and caspase-8 (effector family). Although tubularpolymerase chain reaction analysis since probes for
“housekeeping” genes, such as GAPDH and ribosomal apoptosis reverted to control level beyond day 30, a rise
in mRNAs of apoptosis-related molecules during thisprotein L32, are included. The mRNAs of these genes
are simultaneously detected with those of target genes period probably reflects a continuous rise of interstitial
apoptosis toward the end of the experiment. Apoptosisand serve as internal controls for quantitation.
We found that in mouse kidneys with COU, tubular was virtually not seen in control and contralateral kid-
neys, a finding that correlated with normal or minimallycell apoptosis increased rapidly, peaked at day 15, and
regressed to the baseline toward the end of study. In elevated mRNAs for apoptosis-related molecules in
these kidneys. The available data clearly implicate thesecontrast, apoptosis of interstitial cells maintained a con-
tinuous rise throughout the experimental duration. We molecules in the development of COU-associated renal
cell apoptosis. They also suggest that although the samealso documented a dynamic expression in the obstructed
kidneys of many molecules that may regulate renal cell apoptotic pathways are functional for both renal tubular
and interstitial cells in COU, the molecular controls mayapoptosis in this condition. The rise and fall of tubular
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Fig. 4. (Continued)
be different for these two cellular compartments. Insight with COU. The data obtained by immunostaining, how-
ever, showed some discrepancies with those obtainedinto this possible differential control may be obtained
with immunolocalization of apoptosis-related molecules by ribonuclease protection assay. It was noted that the
immunostaining for several apoptotic promoters becamein various renal compartments. Antibodies suitable for
immunostaining are now available for some of these weaker toward the end of the experiment, at which time
the corresponding mRNAs continued to increase. Inmolecules, including Fas, Fas ligand, TRAIL, TRADD,
RIP, and caspase-8. The immunostaining with these anti- addition, although apoptosis of interstitial cells was
clearly documented, these cells did not show staining forbodies in our study demonstrated that the damaged tubu-
lar cells displayed increased expression of all tested mole- TRAIL, TRADD, RIP, or caspase-8. Although these
discrepancies still await definitive explanation, they maycules, an observation that supports the roles of these
molecules in mediating tubular cell apoptosis in kidney be related to either a post-translational block of protein
Fig. 5. Immunostaining for apoptosis-promoting molecules. Paraffin-embedded kidney tissue stained with Fas (A–C ) and Fas ligand (D–F )
polyclonal antibodies. The expression is noted mostly in atrophic tubules at day 15; there is positive staining for both interstitial and tubular cells
at day 45. Acetone fixed-frozen sections of kidney tissues were stained by TRAIL (G–I ), TRADD (J–L), RIP (M–O), and caspase 8 (P–R)
polyclonal antibodies. The expression is noted in the damaged tubular cells of the cortex at day 15; it is subsequently decreased and limited to a
few tubules at day 45. There was no staining for interstitial cells (avidin-biotin peroxidase, 3600 for all panels).
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synthesis or up-regulated proteolytic degradation of effect of TNF-a, while the type II receptor mainly medi-
ates its proliferation signal [50]. TNF-a is usually synthe-these proteins in the interstitial cells. These discrepancies
may also imply that the control for apoptosis of tubular sized by macrophages, but production by resident renal
cells, including tubular and mesangial cells, was recentlyand interstitial cells may be different. Alternatively, the
protein/messenger mismatch may be of a technical na- demonstrated [51]. TNF-a has been shown to induce
apoptosis in many cell types [52–54], including renal tu-ture and related to a somewhat insensitive nature of
immunostaining that cannot detect a lesser level of apo- bular cell [55], glomerular mesangial cells [56], and renal
fibroblast [57]. Although elevation of mRNA for TNF-aptosis promoters in kidneys with advanced lesions.
How each individual molecule evaluated in our study was found in renal tubular cells in a model of COU in
rat [50, 58], this is the first time an increased expressionmediates COU-associated renal cell apoptosis is not
completely understood. Among members of the death of its receptor is demonstrated.
A fourfold increase in mRNA for TRAIL (TNF-relatedreceptor/ligand family, the Fas/Fas ligand system is best
studied [6, 7, 11–14, 40–46]. The Fas/Fas ligand system apoptosis-inducing ligand) was found in obstructed kid-
neys. TRAIL, the newest member of the TNF family ofwas initially detected as the main pathway for lymphoid
cell apoptosis, but is now known to play a similar role ligands, acts through binding to one of its four known
receptors [59, 60]. TRAIL can induce apoptosis in ain many other types of tissue or organs, including thymus,
liver, lung, thyroid, and kidney [6, 7]. Fas is a 45 kD cell variety of transformed cell lines, but is not cytotoxic
to normal tissues despite the widespread expression ofsurface receptor protein that has been identified in many
cell types, including renal tubular and mesangial cells [6, TRAIL and its receptors, suggesting that strong regula-
tory mechanisms control TRAIL receptor signals [18,7, 16, 41]. Fas ligand, a 40 kD protein identified in acti-
vated lymphoid cells, gut, lung, and kidney, has a specific 19, 59–62]. To the best of our knowledge, the role of the
TRAIL/TRAIL receptor system has never been evalu-cytolytic activity against cells expressing Fas [6, 7, 42].
Signal-transducing machinery for Fas-induced apoptosis ated in any renal diseases, including COU.
This study demonstrated increased expression of sev-is present in most cell types [45], and many apoptotic
signals from environmental death initiators such as lipo- eral adapter molecules in obstructed kidneys, including
FADD (Fas-associated death domain), TRADD (TNFR-1-polysaccharides, interleukin-1b, interferon-g and tumor
necrosis factor-a (TNF-a), are transduced through Fas associated death domain protein), RIP (receptor-inter-
acting protein), FAF (Fas-associated factor), and FAP[6, 16]. Fas/Fas ligand-mediated tubular cell apoptosis
has been shown to be responsible for tubular cell dele- (Fas-associated phosphatase). Although the function of
these molecules is not completely understood, all oftion, which contributes to tubular atrophy in several re-
nal diseases such as chronic renal failure [13], ischemia them, as implied by their full names that are less popular
than the abbreviated ones, share an intracellular locationreperfusion injury [44], glomerulonephritis [46], and
remnant kidney model [47]. This study, to our knowledge and, together, serve as a network through which apo-
ptotic signals from the receptor/ligand family are trans-the first one to implicate Fas/Fas ligand system in the
development of renal lesions in COU, demonstrated in- duced to members of the effector family [17–23, 26–28,
30, 63–66]. Among these adapter molecules, FAP is thecreased mRNA levels of both Fas and Fas ligand in
obstructed kidneys. In addition, immunostaining further only apoptosis inhibitor [24, 25, 27], whereas the remain-
der promotes apoptosis. Since these five adapter mole-suggested that the Fas/Fas ligand system be involved in
tubular apoptosis since it was demonstrated in tubular cules have just recently been identified, mostly from in
vitro studies, practically nothing is known on their rolescells, especially the atrophic ones. The Fas/Fas ligand
system may also mediate interstitial cell apoptosis since in pathologic conditions, including those involving kid-
neys. Our study is the first to implicate these molecules inboth of their mRNA levels continue to increase at time
points between days 30 and 45 when interstitial cell apo- renal cell apoptosis associated with urinary obstruction.
Structural changes characteristic for apoptosis are me-ptosis intensifies, in contrast with a virtual cessation of
tubular cell apoptosis. We also demonstrated the immu- diated by activation of a cascade of caspases, which are
effector molecules of the death pathway [8, 10, 30, 31,nolocalization of Fas and Fas ligand in the interstitial
cells at later time points (days 30 and 45). 64]. A family of at least ten related caspases has been
identified. Caspases are cytosolic or nuclear enzymesA threefold increase in mRNA of TNFR-1 in obstructed
kidneys in this study suggests that the TNFR-1/TNF-a that are synthesized as inactive forms and are activated
by cleavage at specific aspartate residues [8, 67]. Amongpair also mediates renal cell apoptosis in COU. TNF-a is
a type II membrane protein that has numerous biological the caspases, caspase-8 is probably the most crucial since
it serves as link between the adapter molecules and otherfunctions, including cytotoxic and cells proliferative effects
[48, 49]. The cellular effects of TNF-a are mediated mainly caspases. Indeed, caspase-8 is capable of activating all of
the other remaining caspases [68] to bring the apoptoticthrough its receptors, which include types II and I. The
type I receptor is mainly responsible for the apoptotic cascade to completion. The role of the caspase-8 has
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(Fas/APO-1) death-inducing signaling complex. Cell 85:817–827,never been studied in any renal disease including COU.
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In conclusion, the current study documents a dynamic 1070, 1996
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F, Alonso C, Ramiro F, Ortiz- A, Egido J, Ortiz A: Agonisticate most crucial steps of apoptosis. It implicates these
anti-Fas antibodies induce glomerular cell apoptosis in mice in
molecules in COU-associated renal cell apoptosis and vivo. Kidney Int 51:1739–1746, 1997
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